BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9326332)

  • 1. Screening and diagnosis for the fragile X syndrome among the mentally retarded: an epidemiological and psychological survey. Collaborative Fragile X Study Group.
    de Vries BB; van den Ouweland AM; Mohkamsing S; Duivenvoorden HJ; Mol E; Gelsema K; van Rijn M; Halley DJ; Sandkuijl LA; Oostra BA; Tibben A; Niermeijer MF
    Am J Hum Genet; 1997 Sep; 61(3):660-7. PubMed ID: 9326332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A large-scale diagnostic program for the fragile X syndrome among the mentally handicapped. I. An epidemiologic survey].
    de Vries LB; van den Ouweland AM; Mohkamsing S; Sandkuijl LA; Oostra BA; Niermeijer MF
    Ned Tijdschr Geneeskd; 1998 Jul; 142(29):1666-71. PubMed ID: 9890806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A large-scale diagnostic program for the fragile X-syndrome among the mentally retarded. II. Implications for parents and family].
    de Vries LB; Duivenvoorden HJ; Tibben A; Niermeijer MF
    Ned Tijdschr Geneeskd; 1998 Jul; 142(29):1672-5. PubMed ID: 9890807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for the fragile X syndrome among the mentally retarded: a clinical study. The Collaborative Fragile X Study Group.
    de Vries BB; Mohkamsing S; van den Ouweland AM; Mol E; Gelsema K; van Rijn M; Tibben A; Halley DJ; Duivenvoorden HJ; Oostra BA; Niermeijer MF
    J Med Genet; 1999 Jun; 36(6):467-70. PubMed ID: 10874635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening with the FMR1 protein test among mentally retarded males.
    de Vries BB; Mohkamsing S; van den Ouweland AM; Halley DJ; Niermeijer MF; Oostra BA; Willemsen R
    Hum Genet; 1998 Oct; 103(4):520-2. PubMed ID: 9856500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for fragile X syndrome among Brazilian mentally retarded male patients using PCR from buccal cell DNA.
    Christofolini DM; Lipay MV; Ramos MA; Brunoni D; Melaragno MI
    Genet Mol Res; 2006 Jul; 5(3):448-53. PubMed ID: 17117359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for the fragile X syndrome among mentally retarded males by hair root analysis.
    Tunçbilek E; Alikasifoğlu M; Aktas D; Duman F; Yanik H; Anar B; Oostra B; Willemsen R
    Am J Med Genet; 2000 Nov; 95(2):105-7. PubMed ID: 11078558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applicability of a checklist for clinical screening of the fragile X syndrome.
    Arvio M; Peippo M; Simola KO
    Clin Genet; 1997 Oct; 52(4):211-5. PubMed ID: 9383025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An assessment of screening strategies for fragile X syndrome in the UK.
    Pembrey ME; Barnicoat AJ; Carmichael B; Bobrow M; Turner G
    Health Technol Assess; 2001; 5(7):1-95. PubMed ID: 11262423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA testing for fragile X syndrome in 255 males from special schools in Singapore.
    Tan BS; Law HY; Zhao Y; Yoon CS; Ng IS
    Ann Acad Med Singap; 2000 Mar; 29(2):207-12. PubMed ID: 10895341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A step-wise diagnosis of fragile X syndrome in Taiwan.
    Huang YT; Chiang SC; Tzeng CC; Liu CH; Chien YH; Hwu WL
    Acta Paediatr Taiwan; 2004; 45(2):69-72. PubMed ID: 15335113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular screening of FRAXA and FRAXE in Indian patients with unexplained mental retardation.
    Pandey UB; Phadke S; Mittal B
    Genet Test; 2002; 6(4):335-9. PubMed ID: 12537661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetic analysis of mentally retarded males with features of the fragile-X syndrome.
    Butler MG; Pratesi R; Vnencak-Jones CL
    J Intellect Disabil Res; 1995 Dec; 39 ( Pt 6)(Pt 6):544-53. PubMed ID: 8746743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA testing for fragile X syndrome: implications for parents and family.
    van Rijn MA; de Vries BB; Tibben A; van den Ouweland AM; Halley DJ; Niermeijer MF
    J Med Genet; 1997 Nov; 34(11):907-11. PubMed ID: 9391884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of blood spot PCR in large-scale screening of fragile X syndrome in southern Taiwan.
    Chow JC; Chen DJ; Lin CN; Chiu CY; Huang CB; Chiu PC; Lin CH; Lin SJ; Tzeng CC
    J Formos Med Assoc; 2003 Jan; 102(1):12-6. PubMed ID: 12684606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [From gene to disease; fragile X-syndrome: hereditary mental retardation due to a developmental gene].
    de Vries LB; Oostra BA
    Ned Tijdschr Geneeskd; 2001 Mar; 145(10):474-6. PubMed ID: 11268909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot fragile X screening in normal population of Taiwan.
    Tzeng CC; Cho WC; Kuo PL; Chen RM
    Diagn Mol Pathol; 1999 Sep; 8(3):152-6. PubMed ID: 10565687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An effective strategy of using molecular testing to screen mentally retarded individuals for fragile X syndrome.
    Tzeng CC; Lin SJ; Chen YJ; Kuo PL; Jong YJ; Tsai LP; Chen RM
    Diagn Mol Pathol; 2001 Mar; 10(1):34-40. PubMed ID: 11277393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fragile X syndrome.
    de Vries BB; Halley DJ; Oostra BA; Niermeijer MF
    J Med Genet; 1998 Jul; 35(7):579-89. PubMed ID: 9678703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for FMR1 mutations among the mentally retarded: prevalence of the fragile X syndrome in Spain.
    Millán JM; Martínez F; Cadroy A; Gandía J; Casquero M; Beneyto M; Badía L; Prieto F
    Clin Genet; 1999 Jul; 56(1):98-9. PubMed ID: 10466426
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.